These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21318394)

  • 21. Is pervasive developmental disorder not otherwise specified less stable than autistic disorder? A meta-analysis.
    Rondeau E; Klein LS; Masse A; Bodeau N; Cohen D; Guilé JM
    J Autism Dev Disord; 2011 Sep; 41(9):1267-76. PubMed ID: 21153874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between congenital anomalies and autism spectrum disorders in a Finnish national birth cohort.
    Timonen-Soivio L; Vanhala R; Malm H; Leivonen S; Jokiranta E; Hinkka-Yli-Salomäki S; Gissler M; Brown AS; Sourander A
    Dev Med Child Neurol; 2015 Jan; 57(1):75-80. PubMed ID: 25200584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing autism, PDD-NOS, and other developmental disabilities on parent-reported behavior problems: little evidence for ASD subtype validity.
    Snow AV; Lecavalier L
    J Autism Dev Disord; 2011 Mar; 41(3):302-10. PubMed ID: 20556500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparison of DSM-IV-TR and DSM-5 Diagnostic Classifications in the Clinical Diagnosis of Autistic Spectrum Disorder.
    Yaylaci F; Miral S
    J Autism Dev Disord; 2017 Jan; 47(1):101-109. PubMed ID: 27747464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression in children with autism spectrum disorders.
    Malhi P; Singhi P
    Indian J Pediatr; 2012 Oct; 79(10):1333-7. PubMed ID: 22350733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the proposed DSM-5 criteria in a clinical sample.
    Taheri A; Perry A
    J Autism Dev Disord; 2012 Sep; 42(9):1810-7. PubMed ID: 22806000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preference-based health-related quality-of-life outcomes in children with autism spectrum disorders: a comparison of generic instruments.
    Tilford JM; Payakachat N; Kovacs E; Pyne JM; Brouwer W; Nick TG; Bellando J; Kuhlthau KA
    Pharmacoeconomics; 2012 Aug; 30(8):661-79. PubMed ID: 22788258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the childhood autism rating scale to diagnose autism spectrum disorders.
    Chlebowski C; Green JA; Barton ML; Fein D
    J Autism Dev Disord; 2010 Jul; 40(7):787-99. PubMed ID: 20054630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specifying PDD-NOS: a comparison of PDD-NOS, Asperger syndrome, and autism.
    Walker DR; Thompson A; Zwaigenbaum L; Goldberg J; Bryson SE; Mahoney WJ; Strawbridge CP; Szatmari P
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):172-80. PubMed ID: 14726723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of toddlers with ASD: short-term diagnostic and cognitive outcomes.
    Chawarska K; Klin A; Paul R; Macari S; Volkmar F
    J Child Psychol Psychiatry; 2009 Oct; 50(10):1235-45. PubMed ID: 19594835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in autism spectrum disorder diagnoses: 1994-2007.
    Rosenberg RE; Daniels AM; Law JK; Law PA; Kaufmann WE
    J Autism Dev Disord; 2009 Aug; 39(8):1099-111. PubMed ID: 19294498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population.
    Juul-Dam N; Townsend J; Courchesne E
    Pediatrics; 2001 Apr; 107(4):E63. PubMed ID: 11335784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002.
    ;
    MMWR Surveill Summ; 2007 Feb; 56(1):12-28. PubMed ID: 17287715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability and accuracy of differentiating pervasive developmental disorder subtypes.
    Mahoney WJ; Szatmari P; MacLean JE; Bryson SE; Bartolucci G; Walter SD; Jones MB; Zwaigenbaum L
    J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):278-85. PubMed ID: 9519632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.
    Heyer NJ; Echeverria D; Woods JS
    Autism Res; 2012 Apr; 5(2):84-92. PubMed ID: 22298513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of diagnosed autism spectrum disorders in Finland.
    Hinkka-Yli-Salomäki S; Banerjee PN; Gissler M; Lampi KM; Vanhala R; Brown AS; Sourander A
    Nord J Psychiatry; 2014 Oct; 68(7):472-80. PubMed ID: 24359461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How will DSM-5 affect autism diagnosis? A systematic literature review and meta-analysis.
    Kulage KM; Smaldone AM; Cohn EG
    J Autism Dev Disord; 2014 Aug; 44(8):1918-32. PubMed ID: 24531932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood autism rating scale--Tokyo version for screening pervasive developmental disorders.
    Tachimori H; Osada H; Kurita H
    Psychiatry Clin Neurosci; 2003 Feb; 57(1):113-8. PubMed ID: 12519463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in outcome for children with an ASD diagnosis at age 2.
    Turner LM; Stone WL
    J Child Psychol Psychiatry; 2007 Aug; 48(8):793-802. PubMed ID: 17683451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early diagnosis of autism spectrum disorder: stability and change in clinical diagnosis and symptom presentation.
    Guthrie W; Swineford LB; Nottke C; Wetherby AM
    J Child Psychol Psychiatry; 2013 May; 54(5):582-90. PubMed ID: 23078094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.